Skip to main content
abrdn Life Sciences Investors logo

abrdn Life Sciences Investors — Investor Relations & Filings

Ticker · HQL ISIN · US87911K1007 LEI · 5493007BYZPSOVVS0M04 US Financial and insurance activities
Filings indexed 442 across all filing types
Latest filing 2026-03-06 Major Shareholding Noti…
Country US United States of America
Listing US HQL

About abrdn Life Sciences Investors

https://www.aberdeeninvestments.com/en-…

abrdn Life Sciences Investors is a closed-ended equity mutual fund managed by abrdn Inc. The fund's primary investment objective is to seek long-term capital appreciation. It invests globally in a portfolio of securities from public and private companies operating within the life sciences sector. The fund's focus areas include biotechnology, pharmaceuticals, diagnostics, managed healthcare, medical equipment, hospitals, and healthcare information technology and services.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2026
Major Shareholding Notification
2026-03-06 English
Regulatory Filings 2026
Regulatory Filings
2026-02-27 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-02-23 English
SCHEDULE 13D/A Filing
Major Shareholding Notification
2026-02-11 English
SCHEDULE 13D/A Filing
Major Shareholding Notification
2026-01-08 English
3 Filing
Director's Dealing
2025-12-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.